Citations (26)
Keep up to date with the latest research on this topic with citation updates for this article.
Articles from other publishers (26)
Gemma Ferrer-Mayorga, Alberto Muñoz & José Manuel González-Sancho. 2024. Feldman and Pike's Vitamin D. Feldman and Pike's Vitamin D
859
899
.
Anne-Marie Landry-Voyer, Zabih Mir Hassani, Mariano Avino & François Bachand. (2023) Ribosomal Protein uS5 and Friends: Protein–Protein Interactions Involved in Ribosome Assembly and Beyond. Biomolecules 13:5, pages 853.
Crossref
Crossref
Wei-hua Wang, Jia-ming Zhan, Yan-Lei Tang, Ning Zhou, Wei-yan Liu & Dao-wen Jiang. (2022) miR-466 Contributes to the Enhanced Antitumor Effect of Bortezomib on Non-Small-Cell Lung Cancer by Inhibiting CCND1. Chemotherapy 67:2, pages 110-122.
Crossref
Crossref
WeiHua Yin, GuPing Zhong, HuiZhen Fan & HongMei Xia. (2019)
The Effect of Compound
Sophora
on Fluorouracil and Oxaliplatin Resistance in Colorectal Cancer Cells
. Evidence-Based Complementary and Alternative Medicine 2019, pages 1-8.
Crossref
Crossref
Qing Yuan, Hong-Qing Cai, Yi Zhong, Min-Jie Zhang, Zhi-Jian Cheng, Jia-Jie Hao, Ming-Rong Wang & Jing-Hai Wan. (2019) Overexpression of IGFBP2 mRNA predicts poor survival in patients with glioblastoma. Bioscience Reports 39:6.
Crossref
Crossref
Huan Liu, Le Li, Hua Chen, Rui Kong, Shangha Pan, Jisheng Hu, Yongwei Wang, Yilong Li & Bei Sun. (2017) Silencing IGFBP-2 decreases pancreatic cancer metastasis and enhances chemotherapeutic sensitivity. Oncotarget 8:37, pages 61674-61686.
Crossref
Crossref
Amy L. Myers, Lin Lin, Derek J. Nancarrow, Zhuwen Wang, Daysha Ferrer-Torres, Dafydd G. Thomas, Mark B. Orringer, Jules Lin, Rishindra M. Reddy, David G. Beer & Andrew C. Chang. (2015) IGFBP2 modulates the chemoresistant phenotype in esophageal adenocarcinoma. Oncotarget 6:28, pages 25897-25916.
Crossref
Crossref
Leon A. Bach. (2015) Recent insights into the actions of IGFBP-6. Journal of Cell Communication and Signaling 9:2, pages 189-200.
Crossref
Crossref
JIAN ZHANG, WEI WEI, HUI-CHENG JIN, RONG-CHAO YING, A-KAO ZHU & FANG-JIE ZHANG. (2015) Programmed cell death 2 protein induces gastric cancer cell growth arrest at the early S phase of the cell cycle and apoptosis in a p53-dependent manner. Oncology Reports 33:1, pages 103-110.
Crossref
Crossref
Tsai-Hsien Hung, Sheng-Chi Hsu, Ching-Yi Cheng, Kong-Bung Choo, Ching-Ping Tseng, Tse-Ching Chen, Ying-Wei Lan, Tsung-Teng Huang, Hsin-Chih Lai, Chuan-Mu Chen & Kowit-Yu Chong. (2014) Wnt5A regulates ABCB1 expression in multidrug-resistant cancer cells through activation of the non-canonical PKA/β-catenin pathway. Oncotarget 5:23, pages 12273-12290.
Crossref
Crossref
Yantao Du, Danping Wang, Lin Luo & Junming Guo. (2014) miR-129-1-3p Promote BGC-823 Cell Proliferation by Targeting PDCD2. The Anatomical Record 297:12, pages 2273-2279.
Crossref
Crossref
Leon A. Bach, Ping Fu & Zhiyong Yang. (2012) Insulin-like growth factor-binding protein-6 and cancer. Clinical Science 124:4, pages 215-229.
Crossref
Crossref
Kuang-Chi Lai, Chao-Lin Kuo, Heng-Chien Ho, Jai-Sing Yang, Chia-Yu Ma, Hsu-Feng Lu, Hui-Ying Huang, Fu-Shin Chueh, Chien-Chih Yu & Jing-Gung Chung. (2012) Diallyl sulfide, diallyl disulfide and diallyl trisulfide affect drug resistant gene expression in colo 205 human colon cancer cells in vitro and in vivo. Phytomedicine 19:7, pages 625-630.
Crossref
Crossref
L. Kastl, I. Brown & A. C. Schofield. (2011) miRNA-34a is associated with docetaxel resistance in human breast cancer cells. Breast Cancer Research and Treatment 131:2, pages 445-454.
Crossref
Crossref
Weipeng Mu, Robert J. Munroe, Anna K. Barker & John C. Schimenti. (2010) PDCD2 is essential for inner cell mass development and embryonic stem cell maintenance. Developmental Biology 347:2, pages 279-288.
Crossref
Crossref
Ning Li, Yunzhu Long, Xuegong Fan, Hongbo Liu, Cui Li, Lizhang Chen & Zhiming Wang. (2009) Proteomic analysis of differentially expressed proteins in hepatitis B virus-related hepatocellular carcinoma tissues. Journal of Experimental & Clinical Cancer Research 28:1.
Crossref
Crossref
Vivian Goodell, Douglas McNeel & Mary L Disis. (2008) His-tag ELISA for the detection of humoral tumor-specific immunity. BMC Immunology 9:1.
Crossref
Crossref
Fei Bao, Paula Polk, Mary L. Nordberg, Diana M. Veillon, Amanda Sun, Michael Deininger, David Murray, Borje S. Andersson & Reinhold Munker. (2007) Comparative gene expression analysis of a chronic myelogenous leukemia cell line resistant to cyclophosphamide using oligonucleotide arrays and response to tyrosine kinase inhibitors. Leukemia Research 31:11, pages 1511-1520.
Crossref
Crossref
Svetlana MinakhinaMarina DruzhininaRuth Steward. (2007)
Zfrp8
, the
Drosophila
ortholog of
PDCD2
,functions in lymph gland development and controls cell proliferation
. Development 134:13, pages 2387-2396.
Crossref
Crossref
Beverly W. BaronNancy Zeleznik-Le, Miriam J. Baron, Catherine Theisler, Dezheng Huo, Matthew D. KrasowskiMichael J. ThirmanRebecca M. Baron & Joseph M. Baron. (2007)
Repression of the
PDCD2
gene by BCL6 and the implications for the pathogenesis of human B and T cell lymphomas
. Proceedings of the National Academy of Sciences 104:18, pages 7449-7454.
Crossref
Crossref
P J Adam, J A Terrett, G Steers, L Stockwin, J A Loader, G C Fletcher, L-S Lu, B I Leach, S Mason, A C Stamps, R S Boyd, F Pezzella, K C Gatter & A L Harris. (2006) CD70 (TNFSF7) is expressed at high prevalence in renal cell carcinomas and is rapidly internalised on antibody binding. British Journal of Cancer 95:3, pages 298-306.
Crossref
Crossref
Ananda Mookerjee, Jayati Mookerjee Basu, Pranabananda Dutta, Surajit Majumder, Sankar Bhattacharyya, Jaydip Biswas, Smarajit Pal, Pratima Mukherjee, Sanghamitra Raha, Rathindra N. Baral, Tania Das, Thomas Efferth, Gourisankar Sa, Shyamal Roy & Soumitra K. Choudhuri. (2006) Overcoming Drug-Resistant Cancer by a Newly Developed Copper Chelate through Host-Protective Cytokine-Mediated Apoptosis. Clinical Cancer Research 12:14, pages 4339-4349.
Crossref
Crossref
Molly Kulesz-Martin, James Lagowski, Suzanne Fei, Carl Pelz, Rosalie Sears, Marianne Broome Powell, Ruth Halaban & Jodi Johnson. (2005) Melanocyte and Keratinocyte Carcinogenesis: p53 Family Protein Activities and Intersecting mRNA Expression Profiles. Journal of Investigative Dermatology Symposium Proceedings 10:2, pages 142-152.
Crossref
Crossref
Leon A. Bach. (2005) IGFBP-6 five years on; not so ‘forgotten’?. Growth Hormone & IGF Research 15:3, pages 185-192.
Crossref
Crossref
Jannie Borst, Jenny Hendriks & Yanling Xiao. (2005) CD27 and CD70 in T cell and B cell activation. Current Opinion in Immunology 17:3, pages 275-281.
Crossref
Crossref
Yoko Funasaka, Hirofumi Sato, Ashok K. Chakraborty, Akiko Ohashi, George P. Chrousos & Masamitsu Ichihashi. (1999) Expression of Proopiomelanocortin, Corticotropin-Releasing Hormone (CRH), and CRH Receptor in Melanoma Cells, Nevus Cells, and Normal Human Melanocytes. Journal of Investigative Dermatology Symposium Proceedings 4:2, pages 105-109.
Crossref
Crossref